Pathogenic variants in the GBA1 gene, which encodes the enzyme β-glucocerebrosidase, are well-established risk factors for α-synucleinopathies, including PD [30]; however, their impact on the clinical spectrum of PD remains unclear [30]. The gene discussed is GBA1; the disease is synucleinopathy.